Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00276770 · ClinicalTrials.gov registry record · NA
Positron Emission Tomography Using Fluorothymidine F 18 in Finding Recurrent Disease in Patients With Gliomas
A NA study, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT00276770 is a NA study that has completed, run by University of Washington. The registered enrollment target is 12 participants.
The verdict
NCT00276770, a NA study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
RATIONALE: Diagnostic procedures, such as positron emission tomography using fluorothymidine F 18, may be effective in finding recurrent disease in patients with gliomas. PURPOSE: This clinical trial is studying how well positron emission tomography using fluorothymidine F 18 works in finding recurrent disease in patients with gliomas.
Interventions
- PROCEDURE positron emission tomography
- OTHER fluorine F 18 fluorothymidine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2006-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00276770
The ClinicalTrials.gov registry entry for NCT00276770 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which positron emission tomography is the first listed.
NCT00276770 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00276770 about?
NCT00276770 is a clinical study titled "Positron Emission Tomography Using Fluorothymidine F 18 in Finding Recurrent Disease in Patients With Gliomas". RATIONALE: Diagnostic procedures, such as positron emission tomography using fluorothymidine F 18, may be effective in finding recurrent disease in patients with gliomas. PURPOSE: This clinical trial is studying how well positron emission tomography using fluorothymidine F 18 works in finding recur...
What is the current status of trial NCT00276770?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2006-02.
What interventions are being tested in trial NCT00276770?
The interventions under investigation include: positron emission tomography (PROCEDURE), fluorine F 18 fluorothymidine (OTHER).
Who is sponsoring clinical trial NCT00276770?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.